Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2005
08/04/2005US20050169983 Chewable soft capsule
08/04/2005US20050169923 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug
08/04/2005US20050169918 selectively targeting; screening an effect of a Chemokine receptor (CCR4) modulating agent; adjusting the adhesion of T cells to endothelial cells; treating inflammatory skin disease; side effect reduction without affecting on other cells
08/04/2005US20050169914 Novel functions for decay accelerating factor (DAF) in inflammation
08/04/2005US20050169884 Administering an hematopoietic colony stimulating factors of sargramostim; Crohn's Disease
08/04/2005CA2554334A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005CA2554333A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
08/04/2005CA2554188A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005CA2553966A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553242A1 2,6-disubstituted piperidines as modulators of chemokine receptor activity
08/04/2005CA2552763A1 Method of treating type iii hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
08/04/2005CA2495839A1 Anti-photoaging cosmeceutical composition
08/03/2005EP1559716A1 Pyrazolonaphthyridine derivative
08/03/2005EP1559715A1 N-[2-chloro-4-(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559428A1 Receptor regulator
08/03/2005EP1558766A2 Use of a33 antigens and jam-it
08/03/2005EP1558640A2 Trimeric binding proteins for trimeric cytokines
08/03/2005EP1558614A1 Pyridopyrrolizine and pyridoindolizine derivatives
08/03/2005EP1558599A2 Heteroarylpiperidine modulators of chemokine receptor activity
08/03/2005EP1558594A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
08/03/2005EP1558588A2 Compounds, compositions, and methods
08/03/2005EP1558576A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
08/03/2005EP1558559A1 Manufacturing process for no-donating compounds such as no-donating diclofenac
08/03/2005EP1558277A1 Treatment of inflammatory bowel disease
08/03/2005EP1558273A2 Treatment and prevention of pulmonary conditions
08/03/2005EP1558262A1 Water-soluble meloxicam granulates
08/03/2005EP1558258A1 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders
08/03/2005EP1558250A1 Gamma-aminoamide modulators of chemokine receptor activity
08/03/2005EP1558248A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
08/03/2005EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
08/03/2005EP1558230A1 Spirocyclopropyl amides and acids and their therapeutic applications
08/03/2005EP1558225A1 Adhesive composition for dermal patch and production process thereof
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1330166B1 Food grade transglutaminase inhibitor and uses thereof
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
08/03/2005EP1237567B1 Method for administering a cytokine to the central nervous system and the lymphatic system
08/03/2005EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
08/03/2005EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP1012285B1 Beta-defensins
08/03/2005EP0998288B2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
08/03/2005CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/03/2005CN1650014A Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649875A 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases
08/03/2005CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649857A Hydroxamic acid derivatives
08/03/2005CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649826A 5-amino-1-pentene-3-ol substituted derivatives
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
08/03/2005CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
08/03/2005CN1649610A Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and DNA repair proc
08/03/2005CN1649607A A process for the extraction of anthocyanins from black rice and composition thereof
08/03/2005CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum
08/03/2005CN1649597A Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
08/03/2005CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
08/03/2005CN1649589A The treatment of pain with ifendropil
08/03/2005CN1649588A New pharmaceutical compositions based on anticholinergics and PED-IV inhibitors
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
08/03/2005CN1649576A Methods and compositions for treatment of cancer pain
08/03/2005CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/03/2005CN1649568A Pharmaceutical compositions for the treatment of asthma
08/03/2005CN1649551A Drug-delivery endovascular stent and method for treating restenosis
08/03/2005CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
08/03/2005CN1648121A Quinoline deravative, preparing method and its use
08/03/2005CN1647817A Body building wine and its preparing method
08/03/2005CN1647809A Shenjin pill for treating hyperplastic osteoarthritis and rheumatism and its preparing method
08/03/2005CN1647806A Leadless plaster medium for Chinese medicine and preparing method
08/03/2005CN1647804A External medicine spray
08/03/2005CN1647803A Chinese medicine composition plaster for external anti-inflammation and analgetics
08/03/2005CN1647795A Fatty acyl acetaldehyde transfusion preparation and its preparing method
08/03/2005CN1647701A Method for producing soybean trypsin inhibitor concentration
08/03/2005CN1213047C Puring derivatives inhibitors of tyrosine kinase SYK
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213025C 硫代酰胺衍生物 Thioamide derivatives
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1213020C Phenylalaninol derivatives
08/03/2005CN1213017C Propynyl or diene diaryl compounds
08/03/2005CN1212857C Osteodynia alleviating and wind dispelling liniment
08/03/2005CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors
08/03/2005CN1212831C Pharmaceutical preparations
08/02/2005US6924410 single-layer backing of woven or non-woven fabric that has a base of ketoprofen as a non-steroidal anti-inflammatory analgesic; photostability
08/02/2005US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924305 Diazocine derivatives and their use as tryptase inhibitors
1 ... 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 ... 1272